HPA signs unique polio vaccine license deal

The Health Protection Agency (HPA) has recently agreed a non-exclusive Material Transfer, Patent and Know-How License Agreement with the pharmaceutical company GlaxoSmithKline (GSK) for the development and manufacture of a ‘next generation’ polio vaccine which could be a major step in the eradication of polio.
Source: Health Protection Agency - Category: UK Health Source Type: news